Product NDC: | 0019-N450 |
Proprietary Name: | Sodium Iodide I-131 |
Non Proprietary Name: | sodium iodide, i-131 |
Active Ingredient(s): | 5 mCi/mL & nbsp; sodium iodide, i-131 |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0019-N450 |
Labeler Name: | Mallinckrodt Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016515 |
Marketing Category: | NDA |
Start Marketing Date: | 20110822 |
Package NDC: | 0019-N450-F9 |
Package Description: | 1 VIAL in 1 CAN (0019-N450-F9) > 10 mL in 1 VIAL |
NDC Code | 0019-N450-F9 |
Proprietary Name | Sodium Iodide I-131 |
Package Description | 1 VIAL in 1 CAN (0019-N450-F9) > 10 mL in 1 VIAL |
Product NDC | 0019-N450 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sodium iodide, i-131 |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20110822 |
Marketing Category Name | NDA |
Labeler Name | Mallinckrodt Inc. |
Substance Name | SODIUM IODIDE I-131 |
Strength Number | 5 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA] |